[HTML][HTML] Exploring hormone therapy effects on reproduction and health in transgender individuals
E Moustakli, O Tsonis - Medicina, 2023 - mdpi.com
Transgender individuals often face elevated mental health challenges due to gender
dysphoria, but gender-affirming treatments such as surgery and hormone therapy have been …
dysphoria, but gender-affirming treatments such as surgery and hormone therapy have been …
[HTML][HTML] Rodent model of gender-affirming hormone therapies as specific tool for identifying susceptibility and vulnerability of transgender people and future …
R Tassinari, F Maranghi - … Journal of Environmental Research and Public …, 2021 - mdpi.com
Transgenders (TGs) are individuals with gender identity and behaviour different from the
social norms; they often undergo gender-affirming hormone therapy (HT). HT for TG men …
social norms; they often undergo gender-affirming hormone therapy (HT). HT for TG men …
Reversibility of testosterone-induced acyclicity after testosterone cessation in a transgender mouse model
Objective To establish if the cessation of testosterone (T) therapy reverses T-induced
acyclicity in a transgender mouse model that allows for well-defined T cessation timing …
acyclicity in a transgender mouse model that allows for well-defined T cessation timing …
Effects of transmasculine gender-affirming hormone therapy on future reproductive capacity: clinical data, animal models
R Chan-Sui, RE Kruger, E Cho… - …, 2024 - rep.bioscientifica.com
Testosterone gender affirming hormone therapy (T-GAHT) is frequently used by transgender
and gender-diverse individuals assigned female at birth to establish masculinizing …
and gender-diverse individuals assigned female at birth to establish masculinizing …
A Mouse Model to Investigate the Impact of Gender Affirming Hormone Therapy with Estradiol on Reproduction
DR Pfau, AR Schwartz, C Dela Cruz… - Advanced …, 2023 - Wiley Online Library
Gender‐affirming hormone therapy (GAHT) can help transgender and/or gender diverse
(TGD) individuals achieve emobidment goals that align with their transition needs. Clinical …
(TGD) individuals achieve emobidment goals that align with their transition needs. Clinical …
Androgen inhibition of reproductive neuroendocrine function in females and transgender males
AS Kauffman - Endocrinology, 2024 - academic.oup.com
Ovarian function is controlled by pituitary secretion of luteinizing hormone (LH) and follicle
stimulating hormone (FSH), which in turn are governed by gonadotropin releasing hormone …
stimulating hormone (FSH), which in turn are governed by gonadotropin releasing hormone …
Clinical management of transgender and non-binary patients in the fertility preservation service: Current evidence
O Tsonis, J Kopeika - International Journal of Transgender Health, 2023 - Taylor & Francis
Background: Transgender and non-binary individuals face unique challenges when it
comes to fertility preservation (FP). Objective: Despite the growing prevalence of gender …
comes to fertility preservation (FP). Objective: Despite the growing prevalence of gender …
Pharmacokinetic comparison of three delivery systems for subcutaneous testosterone administration in female mice
Transmasculine individuals are often prescribed testosterone (T) for masculinizing hormone
therapy. Mouse models mimicking transmasculine T therapy require reliable long-term T …
therapy. Mouse models mimicking transmasculine T therapy require reliable long-term T …
Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care
NM Shawky, JF Reckelhoff, BT Alexander… - …, 2023 - Am Heart Assoc
Transgender individuals that undergo gender-affirming hormone therapy may experience
discrimination in the health care setting with a lack of access to medical personnel …
discrimination in the health care setting with a lack of access to medical personnel …
[HTML][HTML] A Review of Animal Models Investigating the Reproductive Effects of Gender-Affirming Hormone Therapy
NS Raja, ES Rubin, MB Moravek - Journal of Clinical Medicine, 2024 - mdpi.com
Gender-affirming hormone therapy (GAHT) is an important component in the process of
transitioning for many transgender and gender-diverse (TGD) individuals. Multiple medical …
transitioning for many transgender and gender-diverse (TGD) individuals. Multiple medical …